ALLO vs UPS · rev $22.0K vs P/E 15, rev $88.66B
Allogene Therapeutics Inc (ALLO) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
ALLO currently screens at market cap $258.1M. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the ALLO and UPS stock pages for the full models.
Not investment advice.